Faculty of Biomedical Sciences
Logo USI
Tools
Info for
Italiano

About

Study

Research

Practicalities

News and events

Events
09
June
2023
09.
06.
2023

2023 Annual Meeting of the SSN

IOR Lecture Series - "Genetics, Immunobiology and Targeted Therapy of Hodgkin Lymphoma"

Seminar Prof. Dr. Tamara Bidone - Multiscale models of integrin and integrin adhesions: from all-atom to macromolecular and mesoscale simulations

13
June
2023
13.
06.
2023

The circadian immune system in cancer

14
June
2023
14.
06.
2023

From (membrane) protein interactions to precision medicine

21
June
2023
21.
06.
2023

International PhD Program: Seminars in Biomedical Neurosciences

23
June
2023
23.
06.
2023

IOR Lecture Series - "Immunometabolic editing orchestrates tumor metabolic reprogramming and immune evasion"

08
September
2023
08.
09.
2023

12a Giornata della Ricerca e dell'Innovazione in Medicina Umana della Svizzera italiana

Home / News and events / News

News

Image showing the prostate cancer cells accumulating drops of lipids (in red) in the cytoplasm. The cell nuclei are shown in grey.

Putting cells "on a diet" for new therapies against cancer
Immag of a NUT midline carcinoma, a tumour caused by the alteration of a BET protein (source: Wikipedia)

Interfering with gene expression to fight cancer
Diagram of the Mre11-Rad50-Xrs2 (MRX) complex together with Sae2

A new study from the IRB published in Genes & Development
Antonio Lanzavecchia (photo by Alessandro Crinari)

Antonio Lanzavecchia receives the 2017 Sanofi-Institut Pasteur Award
eaf862be16b617617b65efa6fa679904.jpeg

Confirmed the positive results at the National Fund
Immunohistochemical analysis of diffuse large B cell lymphomas stained for the expression of the BCL2 protein (dark brown colour) (40x)

A new molecule to inhibit lymphoma growth
b863fd648f7a6f473b042abfb9f41ae1.jpeg

The construction site of the new campus in Bellinzona is now open
Il Rettore dell’USI Boas Erez e il Presidente di IBSA Arturo Licenziati

IBSA Foundation scholarships for the Master in Medicine
Prof. Federica Sallusto

Introductory Lecture by Prof. Federica Sallusto at ETH
The antibody (in red) binds to Zika Virus (in blue), preventing it to from escaping the immune system thus blocking the infection.

A double antibody to defeat Zika virus
The image shows fluorescence staining of Plasmodium falciparum-infected red blood cells

Antibody engineering by nature
Prof. Pietro Majno-Hurst, M.D

Pietro Majno-Hurst, M.D., is appointed Professor at USI and Chief physician at the EOC
Rendering of the new IRB-IOR-NSI campus in Bellinzona

IRB celebrates 20 years of scientific progress in Ticino
Professor Antonio Lanzavecchia

Prof. Antonio Lanzavecchia receives the 2017 Robert Koch Award
Sara Ravasio, researchera at the IRB in Bellinzona

Commitment to fundamental research at the service of society
RNA molecule: Regulatory RNAs can be used as targets to combat the onset of cancers (Image: Vossman, Wikipedia).

Innovative therapies against tumors
d589521dbba152dd18281a09acc1b10e.jpeg

The doctor's choice. The rectoverso series continues in Bellinzona
The Academic Senate of USI

First session of the Academic Senate
Credits: François Bianco; license: Creative Commons

New vaccine against RSV virus in the cattle. Possible implications for the development of such a vaccine in humans
65d2ec3e225c31c64daa3ffc6a0da9e6.png

IRB study on DNA recombination published in Genes & Development

Pages

Faculty of Biomedical Sciences
Università della Svizzera italiana
Via Buffi 13
6900 Lugano, Svizzera
tel +41 58 666 49 00
fax +41 58 666 46 47
e-mail [email protected]
Other contacts Feedback on the website

Directions

Stay in touch

© Università della Svizzera italiana
swissuniversities.ch